Vident Investment Advisory, LLC Mesoblast LTD Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$2.95 - $4.44 $1,171 - $1,762
397 Added 1.1%
36,413 $142,000
Q1 2023

May 15, 2023
BUY
$2.94 - $4.18 $23,331 - $33,172
7,936 Added 28.26%
36,016 $118,000
Q4 2022

Feb 14, 2023
BUY
$2.73 - $3.7 $8,711 - $11,806
3,191 Added 12.82%
28,080 $81,000
Q3 2022

Nov 14, 2022
BUY
$0.48 - $3.48 $11,946 - $86,613
24,889 New
24,889 $0

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email